These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23580348)

  • 1. Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.
    Singh T; Katiyar SK
    PLoS One; 2013; 8(4):e60749. PubMed ID: 23580348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
    Singh T; Katiyar SK
    Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Note: Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling.
    PLOS ONE Editors
    PLoS One; 2024; 19(5):e0303600. PubMed ID: 38739616
    [No Abstract]   [Full Text] [Related]  

  • 4. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
    Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE
    Che D; Zhang S; Jing Z; Shang L; Jin S; Liu F; Shen J; Li Y; Hu J; Meng Q; Yu Y
    Mol Immunol; 2017 Oct; 90():197-210. PubMed ID: 28837884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells.
    Vaid M; Prasad R; Sun Q; Katiyar SK
    PLoS One; 2011; 6(7):e23000. PubMed ID: 21829575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway.
    Zhang S; Da L; Yang X; Feng D; Yin R; Li M; Zhang Z; Jiang F; Xu L
    Toxicol Lett; 2014 Mar; 225(2):201-7. PubMed ID: 24374173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.
    Singh T; Katiyar SK
    PLoS One; 2011; 6(10):e25224. PubMed ID: 22022384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.
    Singh T; Prasad R; Katiyar SK
    Epigenetics; 2013 Jan; 8(1):54-65. PubMed ID: 23221619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
    Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
    Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
    Hua H; Chen W; Shen L; Sheng Q; Teng L
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.
    Lv XQ; Qiao XR; Su L; Chen SZ
    Acta Pharmacol Sin; 2016 Dec; 37(12):1574-1586. PubMed ID: 27593221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion.
    Wang L; Sun Y; Yi J; Wang X; Liang J; Pan Z; Li L; Jiang G
    Exp Lung Res; 2016 Sep; 42(7):346-353. PubMed ID: 27607135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DKK1 promotes migration and invasion of non-small cell lung cancer via β-catenin signaling pathway.
    Zhang J; Zhang X; Zhao X; Jiang M; Gu M; Wang Z; Yue W
    Tumour Biol; 2017 Jul; 39(7):1010428317703820. PubMed ID: 28677426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.